<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>58</viewCount><searchCount>0</searchCount></scores><additional><submitter>Jacob A</submitter><funding>BLRD VA</funding><funding>NCATS NIH HHS</funding><funding>Cystic Fibrosis Foundation</funding><funding>NIEHS NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>CReM</funding><funding>NIH</funding><funding>NIGMS NIH HHS</funding><pagination>472-488.e10</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5755620</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(4)</volume><pubmed_abstract>Lung alveoli, which are unique to air-breathing organisms, have been challenging to generate from pluripotent stem cells (PSCs) in part because there are limited model systems available to provide the necessary developmental roadmaps for in vitro differentiation. Here we report the generation of alveolar epithelial type 2 cells (AEC2s), the facultative progenitors of lung alveoli, from human PSCs. Using multicolored fluorescent reporter lines, we track and purify human SFTPC+ alveolar progenitors as they emerge from endodermal precursors in response to stimulation of Wnt and FGF signaling. Purified PSC-derived SFTPC+ cells form monolayered epithelial "alveolospheres" in 3D cultures without the need for mesenchymal support, exhibit self-renewal capacity, and display additional AEC2 functional capacities. Footprint-free CRISPR-based gene correction of PSCs derived from patients carrying a homozygous surfactant mutation (SFTPB&lt;sup>121ins2&lt;/sup>) restores surfactant processing in AEC2s. Thus, PSC-derived AEC2s provide a platform for disease modeling and future functional regeneration of the distal lung.</pubmed_abstract><journal>Cell stem cell</journal><pubmed_title>Differentiation of Human Pluripotent Stem Cells into Functional Lung Alveolar Epithelial Cells.</pubmed_title><pmcid>PMC5755620</pmcid><funding_grant_id>R01 HL095993</funding_grant_id><funding_grant_id>R24HL123828</funding_grant_id><funding_grant_id>U01HL134745</funding_grant_id><funding_grant_id>R01 HL111449</funding_grant_id><funding_grant_id>P30 ES013508</funding_grant_id><funding_grant_id>U01HL099997</funding_grant_id><funding_grant_id>U01TR001810</funding_grant_id><funding_grant_id>R01HL128172</funding_grant_id><funding_grant_id>R01 HL136722</funding_grant_id><funding_grant_id>R01 GM108807</funding_grant_id><funding_grant_id>TL1TR001410</funding_grant_id><funding_grant_id>F31 HL134274</funding_grant_id><funding_grant_id>HL059959</funding_grant_id><funding_grant_id>F31HL134274</funding_grant_id><funding_grant_id>TL1 TR001410</funding_grant_id><funding_grant_id>DAVIS15XX1</funding_grant_id><funding_grant_id>I01 BX001176</funding_grant_id><funding_grant_id>T32 HL007035</funding_grant_id><funding_grant_id>U01 HL134745</funding_grant_id><funding_grant_id>R01 HL122442</funding_grant_id><funding_grant_id>U01 HL099997</funding_grant_id><funding_grant_id>R33 HL120760</funding_grant_id><funding_grant_id>U01 HL134766</funding_grant_id><funding_grant_id>R01 GM120060</funding_grant_id><funding_grant_id>HAWKIN15XX0</funding_grant_id><funding_grant_id>UL1 TR001430</funding_grant_id><funding_grant_id>R01 HL132999</funding_grant_id><funding_grant_id>R01HL095993</funding_grant_id><funding_grant_id>F31HL129777</funding_grant_id><funding_grant_id>R01 HL128172</funding_grant_id><funding_grant_id>K08 HL130582</funding_grant_id><funding_grant_id>U01 TR001810</funding_grant_id><funding_grant_id>R01 HL119436</funding_grant_id><funding_grant_id>R56 HL059959</funding_grant_id><funding_grant_id>R24 HL123828</funding_grant_id><funding_grant_id>F31 HL129777</funding_grant_id><funding_grant_id>DAVISGO</funding_grant_id><funding_grant_id>1UL1TR001430</funding_grant_id><funding_grant_id>R01 HL059959</funding_grant_id><funding_grant_id>R01HL122442</funding_grant_id><funding_grant_id>R33HL120760</funding_grant_id><funding_grant_id>U01HL134766</funding_grant_id><pubmed_authors>Beers MF</pubmed_authors><pubmed_authors>Guttentag SH</pubmed_authors><pubmed_authors>Cole FS</pubmed_authors><pubmed_authors>Davis BR</pubmed_authors><pubmed_authors>Wambach J</pubmed_authors><pubmed_authors>White FV</pubmed_authors><pubmed_authors>Heins H</pubmed_authors><pubmed_authors>Traber K</pubmed_authors><pubmed_authors>Kook S</pubmed_authors><pubmed_authors>Quinton LJ</pubmed_authors><pubmed_authors>Jacob A</pubmed_authors><pubmed_authors>Ochs M</pubmed_authors><pubmed_authors>Crane A</pubmed_authors><pubmed_authors>Jean JC</pubmed_authors><pubmed_authors>Na CL</pubmed_authors><pubmed_authors>Morley M</pubmed_authors><pubmed_authors>Kotton DN</pubmed_authors><pubmed_authors>McCauley KB</pubmed_authors><pubmed_authors>Hawkins F</pubmed_authors><pubmed_authors>Whitsett JA</pubmed_authors><pubmed_authors>Hurley K</pubmed_authors><pubmed_authors>Vedaie M</pubmed_authors><pubmed_authors>Zacharias W</pubmed_authors><pubmed_authors>Morrisey EE</pubmed_authors><pubmed_authors>Weaver TE</pubmed_authors><pubmed_authors>Russo SJ</pubmed_authors><pubmed_authors>Hinds A</pubmed_authors><view_count>58</view_count></additional><is_claimable>false</is_claimable><name>Differentiation of Human Pluripotent Stem Cells into Functional Lung Alveolar Epithelial Cells.</name><description>Lung alveoli, which are unique to air-breathing organisms, have been challenging to generate from pluripotent stem cells (PSCs) in part because there are limited model systems available to provide the necessary developmental roadmaps for in vitro differentiation. Here we report the generation of alveolar epithelial type 2 cells (AEC2s), the facultative progenitors of lung alveoli, from human PSCs. Using multicolored fluorescent reporter lines, we track and purify human SFTPC+ alveolar progenitors as they emerge from endodermal precursors in response to stimulation of Wnt and FGF signaling. Purified PSC-derived SFTPC+ cells form monolayered epithelial "alveolospheres" in 3D cultures without the need for mesenchymal support, exhibit self-renewal capacity, and display additional AEC2 functional capacities. Footprint-free CRISPR-based gene correction of PSCs derived from patients carrying a homozygous surfactant mutation (SFTPB&lt;sup>121ins2&lt;/sup>) restores surfactant processing in AEC2s. Thus, PSC-derived AEC2s provide a platform for disease modeling and future functional regeneration of the distal lung.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Oct</publication><modification>2024-10-16T13:42:16.303Z</modification><creation>2019-03-26T23:58:04Z</creation></dates><accession>S-EPMC5755620</accession><cross_references><pubmed>28965766</pubmed><doi>10.1016/j.stem.2017.08.014</doi></cross_references></HashMap>